Patient registries are expanding across medical fields to collect real-world health data, with dedicated registries now tracking conditions from myasthenia gravis to craniopharyngioma while software platforms supporting these systems are projected to reach billions in market value by 2035.
·US launches myasthenia gravis registry to gather real-world clinical outcomes and treatment patterns
·Urology and neurotech companies deploy specialized registries for urodynamic analysis and future research applications
·Patient registry software market projected to grow from $3.94 billion to $6.78 billion as pregnancy and maternal-child registries expand
·Clinical trials like ELEGANCE registry document real-world device performance for emerging treatments
·AI language models integrated with cannabis registries to support NIDA-funded research studies
drawn from Myasthenia Gravis News, Nature, Barchart.com, PR Newswire · updated 9d ago